Canonical and Non-canonical TGFβ Signaling Activate Autophagy in an ULK1-Dependent Manner

Charles B Trelford1, Gianni M Di Guglielmo1

  • 1Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Insights

Transforming growth factor beta 1 (TGFβ) activates autophagy in lung cancer cells via Smad4 and TAK1-TRAF6-P38 MAPK pathways. These pathways are crucial for regulating autophagy, offering potential therapeutic targets for cancer treatment.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Signaling

Background:

  • The role of transforming growth factor beta 1 (TGFβ) in modulating autophagy within cancer cells is not fully understood.
  • Autophagy is a cellular process implicated in cancer progression and treatment resistance.

Purpose of the Study:

  • To elucidate the specific TGFβ signaling pathways that induce autophagy in non-small cell lung cancer (NSCLC).
  • To identify key molecular players and their interactions in TGFβ-mediated autophagy.
  • To explore potential therapeutic targets for inhibiting TGFβ-driven autophagy in cancer.

Main Methods:

  • Utilized NSCLC cell lines engineered with GFP-LC3-RFP-LC3ΔG constructs to measure autophagic flux.
  • Investigated the impact of TGFβ1 on Unc 51-like kinase 1 (ULK1) phosphorylation and complex formation.
  • Employed siRNA-mediated silencing of Smad4 and inhibition of the TAK1-TRAF6-P38 MAPK pathway.

Main Results:

  • TGFβ1 increased ULK1 levels, AMPK-dependent ULK1 phosphorylation (S555), and ULK1 complex formation, while decreasing mTOR activity.
  • Both the canonical Smad4 pathway and the non-canonical TAK1-TRAF6-P38 MAPK pathway were essential for TGFβ1-induced autophagy.
  • The TAK1-TRAF6-P38 MAPK pathway was critical for downregulating mTOR (S2448) and ULK1 (S555) phosphorylation, impacting autophagosome formation.
  • Smad4 silencing reduced AMPK-dependent ULK1 phosphorylation (S555) and autophagosome formation.
  • Disruption of Smad4 or TAK1-TRAF6-P38 MAPK signaling impaired autophagosome-lysosome co-localization.

Conclusions:

  • The Smad4 and TAK1-TRAF6-P38 MAPK signaling pathways are indispensable for TGFβ-induced autophagy in NSCLC.
  • These pathways regulate key components of the autophagy machinery, including ULK1 and mTOR.
  • Targeting these specific TGFβ signaling pathways could offer a strategy to inhibit autophagy in cancer cells, particularly those undergoing epithelial-mesenchymal transition.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.8K